Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily (RAET)

This study has been completed.
Sponsor:
Information provided by:
Hospitales Universitarios Virgen del Rocío
ClinicalTrials.gov Identifier:
NCT01121809
First received: May 4, 2010
Last updated: February 7, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)